DelveInsight Business Research, LLP: Psoriatic Arthritis Market Sees Major Shift with Growing Biosimilar Adoption | DelveInsight
The arrival of biosimilars like Celltrion's STEQEYMA and Biocon's YESINTEK is shaking up the psoriatic arthritis market, challenging blockbuster biologics with cost-effective alternatives. As ...
Wilsons Reaffirms Their Buy Rating on Clarity Pharmaceuticals Ltd. (CU6)
In a report released on March 6, Shane Storey from Wilsons maintained a Buy rating on Clarity Pharmaceuticals Ltd. (CU6 – Research Report), ...
Analysts Offer Insights on Healthcare Companies: OrthoPediatrics (KIDS) and Mayne Pharma Group (OtherMAYNF)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on OrthoPediatrics (KIDS – Research Report) and ...
TMCnet15d
Innocan Pharma Announces Private Placement Offering of a Debenture Unit to its Largest Shareholder, Tamar Innovest
HERZLIYA, Israel and CALGARY, AB, Feb. 27, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it intends to ...
Finanznachrichten15d
Innocan Pharma Corporation: Innocan Pharma Announces Private Placement Offering of a Debenture Unit to its Largest Shareholder, Tamar Innovest
HERZLIYA, Israel and CALGARY, AB, Feb. 27, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased ...
Morningstar16d
Nasus Pharma To Present Positive Clinical Results From Recent studies of FMXIN002 (NS002) Intranasal Epinephrine at the 2025 AAAAI Annual Meeting
TEL AVIV, Israel, Feb. 27, 2025 /PRNewswire/ -- Nasus Pharma Ltd. ("Nasus Pharma" or the "Company"), a clinical-stage biopharmaceutical company focused on developing needle-free, powder-based ...
Yahoo Finance17d
Mayne Pharma Group Limited (MAYNF)
Despite challenges, Mayne Pharma Group Ltd (MAYNF) reports a 13% revenue increase and significant profitability improvements, driven by robust performance in the women's health segment.
Geelong Advertiser17d
Biocurious: With Mayne Pharmaceuticals under takeover offer, who’s next?
With Mayne Pharma subject to a $670 million takeover offer, investor attention turns to who might be next. Announced on Friday after months of speculation, US pharma giant Cosette launched its $ ...